Skip to main content

Good manufacturing practice

Passing the baton from GPvP to GMP: Three top tips for protecting patients and staying compliant

Gentleman consulting with a pharmacist about the medicine she is holding

A principle objective of both the MHRA and of pharmaceutical companies is to protect and improve the health of patients. When new information about the benefits and risks of a medicine become available it is often appropriate to make changes to the safety information for the product.

Good Manufacturing Practice/Good Distribution Practice Symposium 2019

The MHRA Good Manufacturing/Good Distribution Practice Symposium will be held in London on the 11 to 14 November and in Glasgow on 26 to 27 November 2019. This post details how to secure your place and provides some information about what each of the sessions will include.

Analytical Quality by Design (AQbD): questions and answers

Posted by: , Posted on: - Categories: Compliance matters, Good manufacturing practice, Wider MHRA
Stephen Maddocks and Peter Crowley

This month sees the close of the consultation on the application of Analytical Quality by Design to pharmacopoeial standards. We sat down with Peter and Stephen, pharmacopoeial scientists for the British Pharmacopoeia, to discuss why this consultation may prove vital …

What does qualification of suppliers mean to you? Risks to patients and to your business

A pair of spectacles in front of a computer screen representing careful scrutiny of data

Recent cases of criminal attempts to sell falsified and stolen stock into the legitimate supply chain have exposed weaknesses in some supplier qualification processes. A reminder of what companies need to do to protect themselves, the public and the supply chain.